Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin-resistant Staphylococcus aureus: no apocalypse now.

F W Goldstein, M D Kitzis

    Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
    |November 18, 2003
    PubMed
    Summary

    Vancomycin-resistant Staphylococcus aureus reports often misattribute clinical failures to resistance. Inadequate drug levels and patient factors are more common causes of treatment failure than true vancomycin resistance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnosis and treatment strategies for community-acquired Streptococcus salivarius meningitis.

    Medecine et maladies infectieuses·2013
    Same author

    In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

    International journal of antimicrobial agents·2011
    Same author

    In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2010
    Same author

    [Pleural diffusion of amoxicillin 1 and vancomycin in patients treated for post-surgical empyema].

    Revue des maladies respiratoires·2007
    Same author

    Combating resistance in a challenging, changing environment.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2007
    Same author

    Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin.

    The Journal of antimicrobial chemotherapy·2007

    Area of Science:

    • Infectious Diseases
    • Clinical Microbiology
    • Pharmacology

    Background:

    • Reports of vancomycin-resistant Staphylococcus aureus (VRSA) are increasing.
    • Clinical failures in Staphylococcus aureus infections are often attributed to vancomycin resistance.

    Discussion:

    • Many reported cases of vancomycin resistance are not due to true microbial resistance.
    • Confounding factors frequently contribute to treatment failure in Staphylococcus aureus infections.
    • These factors include inadequate vancomycin serum levels, patient comorbidities, presence of foreign devices, and undrained abscesses.

    Key Insights:

    • The prevalence of true vancomycin resistance in Staphylococcus aureus is lower than suggested by clinical failure reports.
    • Clinical outcomes are often influenced by non-resistance-related factors.

    Related Experiment Videos

  • Accurate diagnosis of vancomycin resistance requires careful consideration of all clinical and microbiological data.

    • Outlook:

    • Further research is needed to differentiate true vancomycin resistance from other causes of treatment failure.
    • Improved diagnostic strategies are essential for accurate VRSA identification.
    • Optimizing vancomycin dosing and managing confounding clinical factors are crucial for successful treatment of Staphylococcus aureus infections.